Background Left ventricular systolic dysfunction in patients with severe aortic stenosis (AS) is associated with poor outcome. The aim was to compare the outcome of patients with severe AS and…
Objectives The objectives were to evaluate long-term follow-up (FU) of mitral balloon valvuloplasty (MBV) with single balloon (SB), the less expensive technique to perform MBV, and to determine independent predictors…
Objectives The objective was to demonstrate that mitral balloon valvuloplasty (MBV) with single balloon, the less expensive technique, has similar outcome and long-term follow-up (FU) than MBV performed with the…
Background Transcatheter aortic valve implantation (TAVI) is an alternative for surgery in patients at high surgical risk. We would like to describe our single-center multimodality experience with transfemoral, transaxillary and…
Background Many patients with severe symptomatic aortic valve stenosis (AS) are considered high surgical risk and therefore are either treated conservatively or undergo balloon valvuloplasty (BV). Some of them may…
Background Transapical aortic valve implantation is a novel therapeutic approach in high-risk patients with severe aortic stenosis. We report a single-center experience during and after the learning curve for establishing…
Background Atrioventricular (AV) conduction abnormalities including complete heart block (CHB) following transcatheter aortic valve implantation (TAVI) are highly variable. The extent to which balloon aortic valvuloplasty (BAV) predilatation contributes to…
Background Severe aortic regurgitation (AR) is a contraindication for aortic balloon valvuloplasty (ABV). However, the effects of ABV in the presence of mild and moderate AR are unknown. Methods A…
Background Routine use of glycoprotein IIb/IIIa inhibitors (GPI) reduces ischemic events during PCI, but this benefit appears to be negated by excessive bleeding complication and thrombocytopenia and did not translate…
Background Thrombolytic therapy is still used for patients presenting with ST-elevation myocardial infarction. The safety and efficacy of bivalirudin (BIV) for primary percutaneous coronary intervention (PCI) in these patients have…
